Cyclin D1 Amplification and p16(MTS1/CDK4I) Deletion Correlate With Poor Prognosis in Head and Neck Tumors

Objectives/Hypothesis Cyclin D1, a cell cycle regulator localized to chromosome 11q13, is amplified in several human tumors including head and neck squamous cell carcinoma (HNSCC). Amplification and/or overexpression of cyclin D1 have been correlated to a poor prognosis. Deletion of the p16 gene, localized to 9p21, has also been observed in a significant proportion of HNSCC. The p16 gene regulates cyclin D1‐CDK4 activity and prevents retinoblastoma tumor suppressor gene phosphorylation, thereby downregulating cellular proliferation. Detection of cyclin D1 amplification and p16 deletion using a simple and sensitive method will be valuable for the development of effective treatment modalities for head and neck cancer.

[1]  阪口 全宏.  Inversely correlated expression of p16 and Rb protein in non-small cell lung cancers : An immunohistochemical study , 2004 .

[2]  D. Slamon,et al.  Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  R. Sutherland,et al.  Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[4]  W. Benedict,et al.  Expression of p16, Rb, and cyclin D1 gene products in oral and laryngeal squamous carcinoma: biological and clinical implications. , 1999, Human pathology.

[5]  J. Jen,et al.  Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma , 1999, Oncogene.

[6]  T. Calcaterra,et al.  Clinical application of fluorescence in situ hybridization for chromosome 11q13 analysis in head and neck cancer , 1999, The Laryngoscope.

[7]  F. Moatamed,et al.  Detection of chromosome 11q13 amplification in head and neck cancer using fluorescence in situ hybridization. , 1999, Anticancer research.

[8]  W. Hong,et al.  Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification , 1998, Oncogene.

[9]  G. Grillone,et al.  Inactivation of p53 and Amplification of Cyclin D1 Correlate With Clinical Outcome in Head and Neck Cancer , 1998, The Laryngoscope.

[10]  M. Kitajima,et al.  Altered p16/MTS1/CDKN2 and cyclin D1/PRAD-1 gene expression is associated with the prognosis of squamous cell carcinoma of the esophagus. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[11]  E. Campo,et al.  p16MTS1/CDK4I mutations and concomitant loss of heterozygosity at 9p21-23 are frequent events in squamous cell carcinoma of the larynx , 1997, Oncogene.

[12]  G. Mohapatra,et al.  Detection of p16 Gene Deletions in Gliomas: A Comparison of Fluorescence in Situ Hybridization (FISH) Versus Quantitative PCR , 1997, Journal of neuropathology and experimental neurology.

[13]  K. Yasumoto,et al.  Prognostic value of the immunohistochemical detection of p16INK4 expression in nonsmall cell lung carcinoma , 1997, Cancer.

[14]  M. Wang,et al.  Deletion analysis of the p16/CDKN2 gene in head and neck squamous cell carcinoma using quantitative polymerase chain reaction method. , 1997, Archives of otolaryngology--head & neck surgery.

[15]  L. Meisner,et al.  A juvenile polyposis tumor suppressor locus at 10q22 is deleted from nonepithelial cells in the lamina propria. , 1997, Gastroenterology.

[16]  F. Mertens,et al.  Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression , 1997, Cancer.

[17]  R. Chaganti,et al.  Cyclin D1 abnormalities and tobacco exposure in head and neck squamous cell carcinoma , 1996, Head & neck.

[18]  J. Bartek,et al.  High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. , 1996, Cancer research.

[19]  D. Niewoehner,et al.  Rb and p16INK4a expression in resected non-small cell lung tumors. , 1996, Cancer research.

[20]  H. Matsuda,et al.  Inversely correlated expression of p16 and Rb protein in non‐small cell lung cancers: An immunohistochemical study , 1996, International journal of cancer.

[21]  A. Sigurdsson,et al.  Loss of heterozygosity on chromosome 9 in human breast cancer: Association with clinical variables and genetic changes at other chromosome regions , 1995, International journal of cancer.

[22]  R. Kratzke,et al.  Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression. , 1995, Cancer research.

[23]  M. Kelley,et al.  Mechanism of inactivation of CDKN2 and MTS2 in non-small cell lung cancer and association with advanced stage. , 1995, Oncogene.

[24]  J. Bartek,et al.  Oncogenic aberrations of p16INK4/CDKN2 and cyclin D1 cooperate to deregulate G1 control. , 1995, Cancer research.

[25]  A. El‐Naggar,et al.  Heterogeneity of the proliferative fraction and cyclin D1/CCND1 gene amplification in head and neck squamous cell carcinoma. , 1995, Cytometry.

[26]  M. Gaffey,et al.  Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Association with poor prognosis. , 1995, Archives of otolaryngology--head & neck surgery.

[27]  S. Steinberg,et al.  Differential inactivation of CDKN2 and Rb protein in non-small-cell and small-cell lung cancer cell lines. , 1995, Journal of the National Cancer Institute.

[28]  A. Kamb,et al.  Cell-cycle regulators and cancer. , 1995, Trends in genetics : TIG.

[29]  A. Klein-Szanto,et al.  Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. , 1994, Cancer research.

[30]  F. Bosch,et al.  PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. , 1994, Cancer research.

[31]  L. Meisner,et al.  Comparison of chromosome aberrations in leiomyoma and leiomyosarcoma using FISH on archival tissues. , 1994, Cancer genetics and cytogenetics.

[32]  J W Gray,et al.  Thick-section fluorescence in situ hybridization on formalin-fixed, paraffin-embedded archival tissue provides a histogenetic profile. , 1994, The American journal of pathology.

[33]  M. Gaffey,et al.  Chromosome 11Q13 amplification in head and neck squamous cell carcinoma. , 1993, Archives of otolaryngology--head & neck surgery.

[34]  S. Shim,et al.  Use of FISH to detect chromosomal translocations and deletions. Analysis of chromosome rearrangement in synovial sarcoma cells from paraffin-embedded specimens. , 1993, The American journal of pathology.

[35]  P. Carroll,et al.  Heterogeneity of erbB-2 gene amplification in bladder cancer. , 1993, Cancer research.

[36]  M. J. van de Vijver,et al.  Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. , 1992, Cancer research.

[37]  N. Hayward,et al.  Analysis of gene amplification in head‐and‐neck squamous‐cell carcinomas , 1991, International journal of cancer.

[38]  T. Tong,et al.  Cancer statistics, 1991 , 1991, CA: a cancer journal for clinicians.

[39]  J. Yang,et al.  Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas. , 1989, Oncogene.

[40]  D. Niewoehner,et al.  Rb and @16@4a Expression in Resected Non-Small Cell Lung Tumors' , 2000 .

[41]  J. Bartek,et al.  Potential role for concurrent abnormalities of the cyclin D1, p16CDKN2 and p15CDKN2B genes in certain B cell non-Hodgkin’s lymphomas. Functional studies in a cell line (Granta 519) , 1997, Leukemia.

[42]  R. Lidereau,et al.  Frequent amplification of 11q13 DNA markers is associated with lymph node involvement in human head and neck squamous cell carcinomas. , 1994, European journal of cancer. Part B, Oral oncology.

[43]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.